side bar
Tuesday, October 20, 2020


UH to aid, develop COVID-19 immunity vaccine

Alongside AuraVax Therapeutics Inc. UH is developing a vaccine towards immunity to diseases such as COVID-19.

AuraVax is a Houston-based biotech company with UH chemical and biomolecular engineering professor Navin Varadarajan as a co-founder.

The technology being developed between both UH and AuraVax is a nasal inhalant vaccine, where ABC13 compared the technology to FluMist.

According to UH, Varadarajan said the technology will hold systematic immunity based on pre-clinical experimentation.

The vaccine technology is using spike proteins to help the virus enter the target cell and neutralize antibodies.

“We plan to stop COVID-19, a respiratory virus, at its point of entry — the nasal cavity — and we believe our intranasal platform is a differentiated approach that will lead to a vaccine with increased efficacy to create sustained immunity to COVID-19,” said Varadarajan to UH.

[email protected]

Tags: , ,

Back to Top ↑
  • Sign up for our Email Edition

  • Follow us on Twitter

  • Polls

    How are your classes going so far?

    View Results

    Loading ... Loading ...